OrbiMed Advisors LLC
- SEC CIK
- 0001055951
- Latest filing
- Aug 14, 2026
GLUE holding history
Monte Rosa Therapeutics, Inc. in every 13F filed by OrbiMed Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GLUE overviewAll 13F holders of GLUEFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −27,369−100.0% | Sold out | Holders |
| Q4 2022 | 27,369 | $208.3K | <0.1% | −90,086−76.7% | Reduced | Holders |
| Q3 2022 | 117,455 | $960.0K | <0.1% | +117,455 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −350,000−100.0% | Sold out | Holders |
| Q2 2021 | 350,000 | $7.95M | 0.1% | +350,000 | New | Holders |